What are the major opportunities in the Adult Malignant Glioma Therapeutics market? What are the strategies for the Adult Malignant Glioma Therapeutics market?

For detailed insights on the major opportunities and strategies in the Adult Malignant Glioma Therapeutics market, Read More

How does the Adult Malignant Glioma Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Adult Malignant Glioma Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Adult Malignant Glioma Therapeutics market growth? SWOT analysis of the Adult Malignant Glioma Therapeutics market.

For detailed insights on the key dynamics influencing the Adult Malignant Glioma Therapeutics market growth and SWOT analysis of the Adult Malignant Glioma Therapeutics industry, Read More

Adult Malignant Glioma Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Adult Malignant Glioma Therapeutics Market Report 2026

Name: Adult Malignant Glioma Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type Of Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types), By Therapy (Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies), By End-User (Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Adult Malignant Glioma Therapeutics Market Overview

• Adult Malignant Glioma Therapeutics market size has reached to $2.47 billion in 2025

• Expected to grow to $3.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%

• Growth Driver: Government Funding Catalyzing Advancements In Adult Malignant Glioma Therapeutics

• Market Trend: Innovations In Small Molecule Targeted Degraders For Adult Malignant Glioma Therapeutics

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Adult Malignant Glioma Therapeutics Market?

An adult malignant glioma is a type of brain tumor that originates in the glial cells of the brain or spinal cord. Adult malignant glioma therapeutics refers to the various treatment options available for malignant gliomas in adults, aiming to improve quality of life and prolong survival.

The main types of adult malignant glioma therapeutics are glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and others. Glioblastoma multiforme (GBM) is an aggressive brain tumor characterized by rapid growth and the infiltration of adjacent brain tissue, typically without distant organ metastasis. The various therapies are chemotherapy, targeted therapy, radiotherapy, and others used in hospitals, specialty clinics, cancer and radiation therapy centers, and others.

Adult Malignant Glioma Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Adult Malignant Glioma Therapeutics Market Size and Share 2026?

The adult malignant glioma therapeutics market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.7 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to limited therapeutic options for malignant gliomas, reliance on standard chemotherapy and radiotherapy, increasing prevalence of adult brain tumors, growth in hospital oncology services, rising awareness of glioma treatment needs.

What Is The Adult Malignant Glioma Therapeutics Market Growth Forecast?

The adult malignant glioma therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to development of targeted molecular therapies, expansion of clinical trials for novel glioma treatments, increasing investment in precision oncology, rising collaborations between biotech and healthcare providers, adoption of advanced radiotherapy and combination therapy techniques. Major trends in the forecast period include increasing development of targeted glioma therapies, rising adoption of combination treatment approaches, expansion of experimental and personalized therapies, growing focus on improving patient quality of life, increased utilization of advanced radiotherapy techniques.

Book your 30 minutes free consultation with our research experts

Global Adult Malignant Glioma Therapeutics Market Segmentation

1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types

2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies

3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users

Subsegments:

1) By Glioblastoma Multiforme: Standard Treatments, Experimental Therapies

2) By Anaplastic Astrocytoma: Chemotherapy Options, Targeted Therapies

3) By Anaplastic Oligodendroglioma: Radiation Therapy, Combination Therapies

4) By Anaplastic Oligoastrocytoma: Surgical Interventions, Adjuvant Therapies

5) By Other Types: Rare Gliomas, Emerging Therapies

What Is The Driver Of The Adult Malignant Glioma Therapeutics Market?

Government funding to support brain cancer research is expected to propel the growth of the adult malignant glioma therapeutics market going forward. Government funding refers to the financial support provided by a government entity, whether at the federal, state, or local level, to various organizations, initiatives, projects, programs, or individuals. Government funding to support brain cancer research can be helpful for adult malignant glioma therapeutics by supporting the development of novel treatments, customized drug development, targeting pyrimidine synthesis, and orphan drug approval. For instance, in June 2023, the Australian Department of Health and Aged Care, an Australia-based government authority, initiated the Australian Brain Cancer Mission with a fund of $136.66 million to support research into brain cancer. The initiative aims to double the survival rates and thereby improve the quality of life of patients with brain cancer, including anaplastic astrocytoma. Therefore, government funding to support brain cancer research drives the adult malignant glioma therapeutics industry.

Key Players In The Global Adult Malignant Glioma Therapeutics Market

Major companies operating in the adult malignant glioma therapeutics market are Johnson & Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan plc, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genentech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.

Global Adult Malignant Glioma Therapeutics Market Trends and Insights

Major companies operating in the adult malignant glioma therapeutics market are developing innovative products, such as small molecule targeted degraders, to provide reliable customer service. A small-molecule targeted degrader is a drug that uses small molecules to induce the degradation of specific proteins by targeting the protein of interest (POI) and an E3 ubiquitin ligase. For instance, in February 2023, Beactica Therapeutics AB, a Sweden-based precision oncology company, received orphan drug designation approval from the U.S. Food and Drug Administration (FDA) for BEA-17 to treat glioblastoma (GBM). It is a small-molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST that has been implicated in the pathogenesis of various cancers, including GBM. BEA-17 works by degrading LSD1 and CoREST, which leads to the reactivation of tumor suppressor genes and the inhibition of cancer cell growth.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Adult Malignant Glioma Therapeutics Market?

In May 2024, Novartis, a Switzerland-based pharmaceutical company, acquired Mariana Oncology for $1 billion. This acquisition aims to strengthen Novartis's pipeline in radioligand therapies (RLTs) for various cancers, including potential applications for solid tumors such as gliomas. Mariana Oncology is a US-based preclinical-stage biotechnology company, providing therapeutics for gliomas.

Regional Outlook

North America was the largest region in the adult malignant glioma therapeutics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adult Malignant Glioma Therapeutics Market?

The adult malignant glioma therapeutics market consists of revenues earned by entities by providing services such as resection, subtotal resection, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult malignant glioma therapeutics market consists of sales of temozolomide, bevacizumab, carmustine, and monoclonal antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adult Malignant Glioma Therapeutics Market Report 2026?

The adult malignant glioma therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adult malignant glioma therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Adult Malignant Glioma Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.7 billion
Revenue Forecast In 2035	$3.94 billion
Growth Rate	CAGR of 9.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type Of Disease, Therapy, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson & Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan plc, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genentech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Adult Malignant Glioma Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Adult Malignant Glioma Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Adult Malignant Glioma Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Adult Malignant Glioma Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Glioma Therapies

4.2.2 Rising Adoption Of Combination Treatment Approaches

4.2.3 Expansion Of Experimental And Personalized Therapies

4.2.4 Growing Focus On Improving Patient Quality Of Life

4.2.5 Increased Utilization Of Advanced Radiotherapy Techniques

5. Adult Malignant Glioma Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Cancer And Radiation Therapy Centers

5.4 Research Institutions

5.5 Academic And Clinical Trial Centers

6. Adult Malignant Glioma Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Adult Malignant Glioma Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Adult Malignant Glioma Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Adult Malignant Glioma Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Adult Malignant Glioma Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Adult Malignant Glioma Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Adult Malignant Glioma Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Adult Malignant Glioma Therapeutics Market Segmentation

9.1. Global Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types

9.2. Global Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies

9.3. Global Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users

9.4. Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Glioblastoma Multiforme, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Treatments, Experimental Therapies

9.5. Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Astrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy Options, Targeted Therapies

9.6. Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligodendroglioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiation Therapy, Combination Therapies

9.7. Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligoastrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgical Interventions, Adjuvant Therapies

9.8. Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rare Gliomas, Emerging Therapies

10. Adult Malignant Glioma Therapeutics Market Regional And Country Analysis

10.1. Global Adult Malignant Glioma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Adult Malignant Glioma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Adult Malignant Glioma Therapeutics Market

11.1. Asia-Pacific Adult Malignant Glioma Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Adult Malignant Glioma Therapeutics Market

12.1. China Adult Malignant Glioma Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Adult Malignant Glioma Therapeutics Market

13.1. India Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Adult Malignant Glioma Therapeutics Market

14.1. Japan Adult Malignant Glioma Therapeutics Market Overview

14.2. Japan Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Adult Malignant Glioma Therapeutics Market

15.1. Australia Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Adult Malignant Glioma Therapeutics Market

16.1. Indonesia Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Adult Malignant Glioma Therapeutics Market

17.1. South Korea Adult Malignant Glioma Therapeutics Market Overview

17.2. South Korea Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Adult Malignant Glioma Therapeutics Market

18.1. Taiwan Adult Malignant Glioma Therapeutics Market Overview

18.2. Taiwan Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Adult Malignant Glioma Therapeutics Market

19.1. South East Asia Adult Malignant Glioma Therapeutics Market Overview

19.2. South East Asia Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Adult Malignant Glioma Therapeutics Market

20.1. Western Europe Adult Malignant Glioma Therapeutics Market Overview

20.2. Western Europe Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Adult Malignant Glioma Therapeutics Market

21.1. UK Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Adult Malignant Glioma Therapeutics Market

22.1. Germany Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Adult Malignant Glioma Therapeutics Market

23.1. France Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Adult Malignant Glioma Therapeutics Market

24.1. Italy Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Adult Malignant Glioma Therapeutics Market

25.1. Spain Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Adult Malignant Glioma Therapeutics Market

26.1. Eastern Europe Adult Malignant Glioma Therapeutics Market Overview

26.2. Eastern Europe Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Adult Malignant Glioma Therapeutics Market

27.1. Russia Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Adult Malignant Glioma Therapeutics Market

28.1. North America Adult Malignant Glioma Therapeutics Market Overview

28.2. North America Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Adult Malignant Glioma Therapeutics Market

29.1. USA Adult Malignant Glioma Therapeutics Market Overview

29.2. USA Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Adult Malignant Glioma Therapeutics Market

30.1. Canada Adult Malignant Glioma Therapeutics Market Overview

30.2. Canada Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Adult Malignant Glioma Therapeutics Market

31.1. South America Adult Malignant Glioma Therapeutics Market Overview

31.2. South America Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Adult Malignant Glioma Therapeutics Market

32.1. Brazil Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Adult Malignant Glioma Therapeutics Market

33.1. Middle East Adult Malignant Glioma Therapeutics Market Overview

33.2. Middle East Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Adult Malignant Glioma Therapeutics Market

34.1. Africa Adult Malignant Glioma Therapeutics Market Overview

34.2. Africa Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Segmentation By Therapy, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Adult Malignant Glioma Therapeutics Market Regulatory and Investment Landscape

36. Adult Malignant Glioma Therapeutics Market Competitive Landscape And Company Profiles

36.1. Adult Malignant Glioma Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Adult Malignant Glioma Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Adult Malignant Glioma Therapeutics Market Company Profiles

36.3.1. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Allergan plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Adult Malignant Glioma Therapeutics Market Other Major And Innovative Companies

Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd.

38. Global Adult Malignant Glioma Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Adult Malignant Glioma Therapeutics Market

40. Adult Malignant Glioma Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Adult Malignant Glioma Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Adult Malignant Glioma Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Adult Malignant Glioma Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Adult Malignant Glioma Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Adult Malignant Glioma Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Adult Malignant Glioma Therapeutics Market, Supply Chain Analysis

Table 4: Global Adult Malignant Glioma Therapeutics Market, Major Raw Material Providers

Table 5: Global Adult Malignant Glioma Therapeutics Market, Major Resource Providers

Table 6: Global Adult Malignant Glioma Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Adult Malignant Glioma Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Adult Malignant Glioma Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Adult Malignant Glioma Therapeutics Market, Major Trends

Table 10: Global Adult Malignant Glioma Therapeutics Market, Major End Users

Table 11: Global Adult Malignant Glioma Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Adult Malignant Glioma Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Adult Malignant Glioma Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Adult Malignant Glioma Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Glioblastoma Multiforme, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Astrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligodendroglioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligoastrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Adult Malignant Glioma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Adult Malignant Glioma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Adult Malignant Glioma Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Adult Malignant Glioma Therapeutics Market - Company Scoring Matrix

Table 99: Johnson & Johnson Private Limited Financial Performance

Table 100: Pfizer Inc. Financial Performance

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: Allergan plc Financial Performance

Table 103: AbbVie Inc. Financial Performance

Table 104: Global Adult Malignant Glioma Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Adult Malignant Glioma Therapeutics Market, Competitive Dashboard

Table 106: Global Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By Type Of Disease, 2025 – 2030

Table 108: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Table 109: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Adult Malignant Glioma Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Adult Malignant Glioma Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Adult Malignant Glioma Therapeutics Market, Supply Chain Analysis

Figure 4: Global Adult Malignant Glioma Therapeutics Market, Major Raw Material Providers

Figure 5: Global Adult Malignant Glioma Therapeutics Market, Major Resource Providers

Figure 6: Global Adult Malignant Glioma Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Adult Malignant Glioma Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Adult Malignant Glioma Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Adult Malignant Glioma Therapeutics Market, Major Trends

Figure 10: Global Adult Malignant Glioma Therapeutics Market, Major End Users

Figure 11: Global Adult Malignant Glioma Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Adult Malignant Glioma Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Adult Malignant Glioma Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Adult Malignant Glioma Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Glioblastoma Multiforme, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Astrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligodendroglioma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Anaplastic Oligoastrocytoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Adult Malignant Glioma Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Adult Malignant Glioma Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Adult Malignant Glioma Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By Type Of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Adult Malignant Glioma Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Adult Malignant Glioma Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Adult Malignant Glioma Therapeutics Market - Company Scoring Matrix

Figure 99: Johnson & Johnson Private Limited Financial Performance

Figure 100: Pfizer Inc. Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: Allergan plc Financial Performance

Figure 103: AbbVie Inc. Financial Performance

Figure 104: Global Adult Malignant Glioma Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Adult Malignant Glioma Therapeutics Market, Competitive Dashboard

Figure 106: Global Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By Type Of Disease, 2025 – 2030

Figure 108: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Figure 109: Global, Adult Malignant Glioma Therapeutics Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Glioma Treatment Market Report 2026 - Global Outlook – By Type (Low-Grade, High-Grade), By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases), By Route Of Administrati...

Pontine Glioma Drugs Market Report 2026 - Global Outlook – By Type (Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Appli...

Brain Tumor Drugs Market Report 2026 - Global Outlook – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users), By Mechanism of Action (Che...

Glioblastoma Multiforme (GBM) Treatment Market Report 2026 - Global Outlook – By Treatment (Surgery, Radiation Therapy, Chemotherapy, R Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafe...

Pet Cancer Therapeutics Market Report 2026 - Global Outlook – By Cancer Type (Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer), By Species (Dogs, Cats, Other Species), By Therapy (Chemotherapy, Rad...

Glioblastoma Multiforme Market Report 2026 - Global Outlook – By Drug Class (Chemotherapy Agents, Temozolomide, Carmustine, Lomustine, Other Drug Classes), By Diagnostic Tools (Magnetic Resonance Imaging (MRI), Computed ...

Solid Tumor Cancer Treatment Market Report 2026 - Global Outlook – By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures), By Application (Breast Cancer, Cervical Cancer, Colorectal...

Frequently Asked Questions

How big is the Adult Malignant Glioma Therapeutics Market?

The Adult Malignant Glioma Therapeutics market was valued at $2.47 billion in 2025, increased to $2.7 billion in 2026, and is projected to reach $3.94 billion by 2030.

What is the Adult Malignant Glioma Therapeutics market growth?

The global Adult Malignant Glioma Therapeutics market is expected to grow at a CAGR of 9.9% from 2026 to 2035 to reach $3.94 billion by 2035.

Who are the key players in Adult Malignant Glioma Therapeutics market?

Some Key Players in the Adult Malignant Glioma Therapeutics market Include, Johnson & Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan plc, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genentech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd. .

What is the anticipated growth trend for the Adult Malignant Glioma Therapeutics market?

Major trend in this market includes: Innovations In Small Molecule Targeted Degraders For Adult Malignant Glioma Therapeutics. For further insights on this market. request a sample here

Which region has the most growth potential in the Adult Malignant Glioma Therapeutics market?

North America was the largest region in the adult malignant glioma therapeutics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult malignant glioma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.